Castle Biosciences Inc (CSTL)

EBITDA Growth

-21.84%

Quarterly · Period ending:

CSTL logo

CSTL EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-21.84%
CSTL Quarterly EBITDA YoY % (91.60% → -21.84%)
High-resolution chart · PNG

CSTL ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Castle Biosciences Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-21.8408%
-394.8718%
-92.0917%
-71.2741%
-71.3839%
305.7803%
1,906.5693%
425.2367%
173.19%
103.2897%
103.8666%
78.6547%
-1,515.4162%
-17.7255%
-29.2856%
-61.8389%
88.0643%
-451.8903%
-222.4235%
-184.3252%
-1,514.2574%
-384%
-242.0371%
-153.5538%
-198.8191%
661.7756%
-35.046%
351.1991%
120.0429%
91.602%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.